Assignee
MYLAN LABORATORIES LTD
IN·20 granted patents·24 pending applications·9 citations·filing 2014–2025
Top patents by PatentIndex Score
44 records- 0170US10087193B2Crystalline forms of dolutegravir sodiumMYLAN LABORATORIES LTD·Filed 2015·Granted Oct 2, 2018·4 cites·15 claims
- 0267US9975864B2Preparation of cobicistat intermediatesMYLAN LABORATORIES LTD·Filed 2014·Granted May 22, 2018·1 cites·3 claims
- 0366US9902751B2Process for the preparation of empagliflozinMYLAN LABORATORIES LTD·Filed 2014·Granted Feb 27, 2018·4 cites·14 claims
- 0457US2020261479A1Processes for the preparation of amorphous tenofovir alafenamide hemifumarate and a premix thereofMYLAN LABORATORIES LTD·Filed 2019·Application pending·0 cites
- 0553US2017035911A1Amorphous Cobicistat Solid DispersionMYLAN LABORATORIES LTD·Filed 2014·Application pending·0 cites
- 0650US2025352478A1Pharmaceutical composition comprising meloxicamMYLAN LABORATORIES LTD·Filed 2025·Application pending·0 cites
- 0750US2025352479A1Pharmaceutical composition comprising meloxicamMYLAN LABORATORIES LTD·Filed 2025·Application pending·0 cites
- 0850US2025352552A1Pharmaceutical composition comprising meloxicamMYLAN LABORATORIES LTD·Filed 2025·Application pending·0 cites
- 0949US9725412B2Polymorphic forms of perindopril (L)-arginine and process for the preparation thereofMYLAN LABORATORIES LTD·Filed 2015·Granted Aug 8, 2017·0 cites·12 claims
- 1049US2024277726A1Pharmaceutical composition comprising meloxicamMYLAN LABORATORIES LTD·Filed 2021·Application pending·0 cites
- 1148US9994520B2Enzymatic process for the preparation of (S)-5-(4-fluoro-phenyl)-5-hydroxy-1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibeMYLAN LABORATORIES LTD·Filed 2016·Granted Jun 12, 2018·0 cites·10 claims
- 1247US12398100B2Methods and intermediates for preparing hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamideMYLAN LABORATORIES LTD·Filed 2020·Granted Aug 26, 2025·0 cites·17 claims
- 1347US10800777B2Polymorphic forms of VENCLEXTAMYLAN LABORATORIES LTD·Filed 2017·Granted Oct 13, 2020·0 cites·2 claims
- 1444US10710999B2Polymorph of an intermediate for palbociclib synthesisMYLAN LABORATORIES LTD·Filed 2017·Granted Jul 14, 2020·0 cites·7 claims
- 1544US10562866B2Amorphous trisodium sacubitril valsartan and a process for the preparation thereofMYLAN LABORATORIES LTD·Filed 2016·Granted Feb 18, 2020·0 cites·15 claims
- 1644US10479782B2Forms of lumacaftor and processes for the preparation thereofMYLAN LABORATORIES LTD·Filed 2016·Granted Nov 19, 2019·0 cites·5 claims
- 1743US10738071B2Polymorphic forms of sofosbuvirMYLAN LABORATORIES LTD·Filed 2017·Granted Aug 11, 2020·0 cites·20 claims
- 1843US9630909B2Process for the preparation of nepafenacMYLAN LABORATORIES LTD·Filed 2014·Granted Apr 25, 2017·0 cites·20 claims
- 1943US2021317086A1Tramadol HBR-Celecoxib Co-CrystalMYLAN LABORATORIES LTD·Filed 2019·Application pending·0 cites
- 2041US11466031B2Polymorphic forms of bictegravir and its sodium saltMYLAN LABORATORIES LTD·Filed 2019·Granted Oct 11, 2022·0 cites·5 claims
- 2141US10370329B2Process for the enantiomeric resolution of apremilast intermediatesMYLAN LABORATORIES LTD·Filed 2016·Granted Aug 6, 2019·0 cites·4 claims
- 2241US2016362391A1Improved Process for the Preparation of Pomalidomide and its PurificationMYLAN LABORATORIES LTD·Filed 2014·Application pending·0 cites
- 2340US10487067B2Process for the preparation of velpatasvirMYLAN LABORATORIES LTD·Filed 2016·Granted Nov 26, 2019·0 cites·8 claims
- 2438US2018362580A1Crystalline and amorphous forms of carfilzomibMYLAN LABORATORIES LTD·Filed 2016·Application pending·0 cites
- 2538US2022177513A1Process for the Preparation of AbaloparatideMYLAN LABORATORIES LTD·Filed 2020·Application pending·0 cites
- 2638US2022002283A1Meloxicam co-crystalsMYLAN LABORATORIES LTD·Filed 2019·Application pending·0 cites
- 2737US10100075B2Process for the preparation of sofosbuvirMYLAN LABORATORIES LTD·Filed 2014·Granted Oct 16, 2018·0 cites·4 claims
- 2837US2017348334A1Processes for the preparation of amorphous tenofovir alafenamide hemifumarate and a premix thereofMYLAN LABORATORIES LTD·Filed 2015·Application pending·0 cites
- 2936US9796750B2Process for the purification of fluticasone propionate using a ketone solvent and water as anti-solventMYLAN LABORATORIES LTD·Filed 2015·Granted Oct 24, 2017·0 cites·4 claims
- 3035US2021000809A1Process for the preparation of abametapir and its pharmaceutically acceptable saltsMYLAN LABORATORIES LTD·Filed 2019·Application pending·0 cites
- 3134US2018064714A1Process for the Preparation of Amorphous Idelalisib and its PremixMYLAN LABORATORIES LTD·Filed 2016·Application pending·0 cites
- 3234US2021363184A1Process for preparation of pure plecanatideMYLAN LABORATORIES LTD·Filed 2019·Application pending·0 cites
- 3332US2018282351A1Amorphous Ixazomib CitrateMYLAN LABORATORIES LTD·Filed 2016·Application pending·0 cites
- 3431US2020031769A1Novel polymorphs of (5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamide hydrochlorideMYLAN LABORATORIES LTD·Filed 2018·Application pending·0 cites
- 3529US10344009B2Process for the preparation of sofosbuvirMYLAN LABORATORIES LTD·Filed 2016·Granted Jul 9, 2019·0 cites·15 claims
- 3629US2019177317A1Process for the preparation of venetoclaxMYLAN LABORATORIES LTD·Filed 2017·Application pending·0 cites
- 3729US2019160002A1Process for preparing sterile aripiprazole formulationMYLAN LABORATORIES LTD·Filed 2017·Application pending·0 cites
- 3828US2017319539A1Amorphous EmpagliflozinMYLAN LABORATORIES LTD·Filed 2015·Application pending·0 cites
- 3926US2017253585A1Processes for the preparation of intermediates of raltegravirMYLAN LABORATORIES LTD·Filed 2015·Application pending·0 cites
- 4025US2018030038A1Polymorphic Forms of Afatinib DimaleateMYLAN LABORATORIES LTD·Filed 2016·Application pending·0 cites
- 4124US10391178B2Premix of crystalline raltegravir potassium salt and a process for the preparation thereofMYLAN LABORATORIES LTD·Filed 2015·Granted Aug 27, 2019·0 cites·8 claims
- 4223US2017247359A1Process for the preparation of canagliflozinMYLAN LABORATORIES LTD·Filed 2015·Application pending·0 cites
- 4323US2017129893A1Novel Crystalline Form of LevomefolateMYLAN LABORATORIES LTD·Filed 2015·Application pending·0 cites
- 4418US10730888B2Process for the preparation of dolutegravirMYLAN LABORATORIES LTD·Filed 2016·Granted Aug 4, 2020·0 cites·16 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →